Biocatalyst developer Codexis (NASDAQ:CDXS) falls 12.9% AH after announcing CEO Alan Shaw has resigned to "pursue other interests." Peter Strumph, head of the company's pharmaceuticals division, will serve as interim CEO while the board searches for a full-time replacement. Codexis shares tumbled last week following the company's Q4 miss.
Biocatalyst developer Codexis (NASDAQ:CDXS) falls 12.9% AH after announcing CEO Alan Shaw has...
Recommended For You
More Trending News
About CDXS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CDXS | - | - |
Codexis, Inc. |